<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2025.1536540</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Case report: Clinical management of freshwater stingray wounds using negative pressure therapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Nattrodt</surname> <given-names>Janio J. M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2969557/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Bezerra-de-Freitas</surname> <given-names>Vict&#x00F3;ria A.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2969648/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Merval</surname> <given-names>Ana Paula S. S.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2969634/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Filardi</surname> <given-names>Eloise T.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cerni</surname> <given-names>Felipe A.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/764581/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Dantas</surname> <given-names>Domingos S. M.</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2969538/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Lins</surname> <given-names>Alysson B. M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2969766/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Galan</surname> <given-names>Luis E. B.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Carbonell</surname> <given-names>Roberto C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Pucca</surname> <given-names>Manuela B.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/41350/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>General Hospital of Roraima</institution>, <addr-line>Boa Vista</addr-line>, <country>Brazil</country></aff>
<aff id="aff2"><sup>2</sup><institution>Medical School, Federal University of Roraima (UFRR)</institution>, <addr-line>Boa Vista</addr-line>, <country>Brazil</country></aff>
<aff id="aff3"><sup>3</sup><institution>Graduate Program in Health and Science (PROCISA), Federal University of Roraima (UFRR)</institution>, <addr-line>Boa Vista</addr-line>, <country>Brazil</country></aff>
<aff id="aff4"><sup>4</sup><institution>Graduate Program in Bioscience and Biotechnology Applied to Pharmacy, School of Pharmaceutical Sciences, S&#x00E3;o Paulo State University (UNESP)</institution>, <addr-line>Araraquara</addr-line>, <country>Brazil</country></aff>
<aff id="aff5"><sup>5</sup><institution>Programa Doutoral de Bio&#x00E9;tica da Faculdade de Medicina do Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Clinical Analysis, School of Pharmaceutical Sciences, S&#x00E3;o Paulo State University (UNESP)</institution>, <addr-line>Araraquara</addr-line>, <country>Brazil</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Andreas Recke, University of L&#x00FC;beck, Germany</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Devi Prasad Mohapatra, Jawaharlal Institute of Postgraduate Medical Education and Research, India</p>
<p>Behnaz Akbari, Purdue University, United States</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Manuela B. Pucca, <email>manuela.pucca@unesp.br</email></corresp>
<corresp id="c002">Roberto C. Carbonell, <email>rcccarbonell@yahoo.es</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>03</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1536540</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Nattrodt, Bezerra-de-Freitas, Merval, Filardi, Cerni, Dantas, Lins, Galan, Carbonell and Pucca.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Nattrodt, Bezerra-de-Freitas, Merval, Filardi, Cerni, Dantas, Lins, Galan, Carbonell and Pucca</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Stingray injuries represent a significant occupational hazard, particularly for fishermen, and are commonly caused by freshwater stingrays of the Potamotrygonidae family. These stingrays are equipped with a sharp, bilaterally serrated spine that delivers venom, inducing vasoconstriction, severe pain, and ischemia. Such injuries are not only intensely painful but also debilitating, often rendering victims unable to work for weeks or even months. Traditional self-treatment practices, including the application of urine and herbal remedies, are widely relied upon in affected communities but are scientifically unproven and frequently lead to delayed or suboptimal care. This study presents two clinical cases of freshwater stingray envenomation from Roraima, the northernmost state of Brazil located within the Amazon Rainforest. Both cases were managed at the infectious disease unit of the General Hospital in Boa Vista, the state capital. Patients received evidence-based medical care, including intravenous antibiotic therapy and surgical debridement to remove necrotic and devitalized tissue. In one case, advanced negative pressure wound therapy (NPWT) was utilized during dressing changes, resulting in a clean wound devoid of edema and necrotic tissue, demonstrating the technique&#x2019;s effectiveness in promoting wound healing. By accelerating wound healing and mitigating complications such as infections and chronic wounds, NPWT significantly enhance patient outcomes. Furthermore, this study underscores the limitations of traditional remedies and advocates for the adoption of evidence-based interventions, particularly in regions like the Brazilian Amazon, where access to healthcare can be challenging.</p>
</abstract>
<kwd-group>
<kwd>ichthyism</kwd>
<kwd>stingray accident</kwd>
<kwd>stingray management</kwd>
<kwd>epidemiology</kwd>
<kwd>Amazon</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="27"/>
<page-count count="7"/>
<word-count count="4836"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Dermatology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Brazil hosts the world&#x2019;s largest river network, where venomous animals hold a significant ecological and public health presence. Among these, freshwater stingrays of the Potamotrygonidae family are particularly noteworthy. These generally docile creatures rarely exhibit aggression toward humans; however, they adopt defensive behaviors when accidentally stepped on or when their fins are inadvertently touched (<xref ref-type="bibr" rid="ref1">1</xref>). In such cases, the stingray injects venom through its sharp, bilaterally serrated spine, resulting in irregular wounds or lacerations (<xref ref-type="bibr" rid="ref2">2</xref>). Injuries caused by these animals are categorized under ichthyism. More specifically, acanthotoxic ichthyism, associated with venomous fish such as stingrays, is defined by traumatic or necrotic wounds accompanied by severe pain. The most commonly affected anatomical regions include the feet and heels in swimmers, whereas fishermen are particularly prone to hand injuries when handling stingrays (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>). The injuries present with a range of symptoms, including intense pain, skin necrosis, blister formation, ulceration, and fever. In severe cases, involving vital organ damage or bacterial infections, fatalities may occur (<xref ref-type="bibr" rid="ref5">5</xref>). Victims often report pain disproportionate to the size of the injury, which typically subsides within 6 to 48&#x202F;h but can persist for days or even weeks in some cases. The wounds usually exhibit jagged edges, profuse bleeding, and contamination with fragments of the stingray&#x2019;s tegumentary layer (<xref ref-type="bibr" rid="ref6">6</xref>).</p>
<p>Initial stages of envenomation are marked by erythema and edema around the wound, followed by central necrosis, which leads to tissue sloughing and the formation of deep ulcers. Systemic complications, such as nausea, vomiting, hypersalivation, sweating, respiratory depression, muscle fasciculations, and seizures, may also occur (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>). Epidemiological studies on freshwater stingray injuries in Brazil remain limited (<xref ref-type="bibr" rid="ref1">1</xref>). While cases have been documented in the Paran&#x00E1;, Paraguay, and Araguaia river basins, the Amazon rainforest region accounts for the highest incidence of such accidents (<xref ref-type="bibr" rid="ref9">9</xref>). Despite being a significant public health concern in the Amazon, these injuries receive comparatively less attention than snakebites and incidents involving venomous arthropods.</p>
<p>Given the lack of specific treatments for stingray injuries and the limited training healthcare professionals receive on this subject, disseminating information is crucial. Recommended first aid includes gently irrigating the wound with saline water to remove fragments of the spine, glandular tissue, and tegumentary debris. Spine removal should only be performed if the spine is superficially embedded and not penetrating vital areas like the neck, chest, or abdomen, or causing deep limb injuries. For significant bleeding, applying local pressure is essential (<xref ref-type="bibr" rid="ref6">6</xref>).</p>
<p>Literature and clinical experience suggest immediate pain control through immersion of the affected limb in non-scalding hot water (approximately 60&#x00B0;C). Heat inactivates the polypeptide-based, thermolabile toxins&#x2014;such as serotonin, phosphodiesterase, and 5-nucleotidase&#x2014;that are responsible for pain and vasoconstriction. Early excision of necrotic tissue may be beneficial, although determining the extent of necrosis during early stages can be challenging. Chronic complications should be managed with wound healing protocols, and supportive care is recommended for systemic symptoms. Prophylactic tetanus vaccination, wound elevation, antibiotics, and surgical wound closure may also be required (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref6">6</xref>).</p>
<p>Negative Pressure Wound Therapy (NPWT) is an effective approach for treating complex, traumatic, and surgical wounds, as well as burns, necrotic lesions, and pressure or diabetic ulcers. It has also been used for skin grafts to enhance vascularization and improve graft acceptance rates. NPWT has been successfully applied in various clinical scenarios, demonstrating its versatility and effectiveness. It has been used in complex surgical wounds, particularly dehiscent wounds, to improve healing by reducing the risk of infection. In diabetic foot ulcers, NPWT has been widely employed to aid healing and reduce the risk of amputations. It has also proven effective in managing traumatic wounds, accelerating recovery and enhancing the formation of healthy tissue. Additionally, NPWT has been utilized to stabilize and improve the integration of skin grafts, ensuring better vascularization and adherence. In burn cases, the therapy has helped reduce excess exudate, prevent infections, and create a favorable environment for recovery. These examples highlight the diverse applications of NPWT in clinical practice, consistently aiming to improve patient outcomes (<xref ref-type="bibr" rid="ref10">10</xref>). Additionally, the combination of NPWT with dermal regeneration matrices was analyzed in a study published in the Brazilian Journal of Burns, which demonstrated the effectiveness of the technique in integrating skin grafts and accelerating the maturation time in patients with deep wounds and extensive burns (<xref ref-type="bibr" rid="ref11">11</xref>). Moreover, a review demonstrated the application of NPWT in both acute and chronic wounds, emphasizing its ability to remove exudate and promote healing in severe infection cases (<xref ref-type="bibr" rid="ref12">12</xref>). More recent studies further support these findings, demonstrating the applicability of NPWT in other clinical contexts. For instance, NPWT was used in preventing complications in surgical wounds following total knee arthroplasty, showing positive results such as reduced infections and faster wound closure (<xref ref-type="bibr" rid="ref13">13</xref>). Those data confirm that NPWT is an effective and versatile tool in managing high-complexity wounds, offering safe and efficient solutions across different therapeutic settings.</p>
<p>Therefore, NPWT&#x2019;s primary goals include cost-effectiveness, pain reduction, shorter hospital stays, and improved healing outcomes (<xref ref-type="bibr" rid="ref14">14</xref>). The technique involves placing an open-pore hydrophobic polyurethane spongeor sterile gauze which comes into direct contact with the wound bed, covering the entire space, including cavities and tunnels. The sponge can be replaced within a time frame of 5 to 8&#x202F;days depending on the clinical criteria. On top of this structure, a transparent and hermetic adhesive dressing is applied, isolating the area. A plastic tube connected to the dressing allows drainage of exudates into a reservoir linked to a computerized device, which continuously or intermittently regulates the negative pressure. The applied pressure ranges from &#x2212;75&#x202F;mmHg to &#x2212;125&#x202F;mmHg, depending on the complexity and needs of the wound, promoting more efficient healing. This process results in benefits such as the removal of fluids and inflammatory mediators, reduction of bacterial load, and approximation of the wound edges, facilitating closure (<xref ref-type="bibr" rid="ref15">15</xref>).</p>
<p>The mechanisms of action of NPWT encompass both physical and biological aspects. Macrodeformation, promoted by negative pressure, reduces the wound size by bringing the edges closer together, while microdeformation acts at the cellular level, stimulating fibroblast proliferation and angiogenesis, which are crucial for tissue regeneration. Furthermore, the system creates a controlled moist environment, which accelerates the formation of granulation tissue and minimizes the risk of necrosis. Another significant benefit is the ability to remove exudates rich in bacteria and inflammatory substances, reducing the risk of infection and keeping the area cleaner and more prepared for natural healing processes. Studies highlight that NPWT is especially effective in traumatic wounds, postoperative wounds, pressure ulcers, and burns, showing shorter healing times and reduced complications compared to traditional techniques (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>). NPWT is widely adopted globally to prepare wound beds for definitive closure (<xref ref-type="bibr" rid="ref12">12</xref>). Given its therapeutic benefits, NPWT is a valuable option for managing stingray injuries.</p>
<p>The treatment of wounds caused by stingrays is particularly challenging due to the complexity of the injuries, which often involve deep trauma, bacterial infection, and venom contamination (<xref ref-type="bibr" rid="ref18">18</xref>). Thus, NPWT promises to be a valuable approach for accelerating the healing of these wounds, offering benefits in both clinical recovery and improvement in patients&#x2019; life quality. By removing exudates, reducing inflammation, and minimizing bacterial load, NPWT creates an ideal environment for tissue regeneration and accelerates wound closure. This can reduce hospitalization time and the need for additional treatments, allowing patients to return to their daily activities more quickly, which directly impacts their psychological and emotional well-being. For patients with stingray injuries, especially in visible areas, faster healing can restore self-esteem and confidence, leading to a more peaceful physical and emotional recovery. This report presents two cases of fishermen injured by freshwater stingrays, both of whom developed severe ulcerative lesions accompanied by significant edema. These injuries necessitated specialized treatment, including the surgical debridement of necrotic and devitalized tissue to promote wound healing. The cases are compared based on the therapeutic approach: one utilizing negative pressure wound therapy, which effectively reduced edema and facilitated wound healing, and the other treated without this advanced method.</p>
</sec>
<sec id="sec2">
<title>Case series presentation</title>
<sec id="sec3">
<title>Case report 1</title>
<p>A 59-year-old male fisherman resident of the municipality of Mucaja&#x00ED;, Roraima, with a medical history of hypertension and type 2 diabetes mellitus, under treatment with losartan, metformin, and glibenclamide, presented to the emergency department of the General Hospital of Roraima (HGR) on May 12, 2023. The patient sought medical attention 6&#x202F;days after sustaining a stingray injury to the lateral malleolar region of his left ankle. He reported severe pain accompanied by significant localized edema and hyperemia. Prior to this visit, the patient had sought care at a local urgent care facility, where it was prescribed cephalexin, which he used for 3&#x202F;days without improvement.</p>
<p>On May 14, 2023, he was transferred to the infectious disease service of the HGR. The laboratory tests revealed leukocytosis, neutrophilia, and elevated C-reactive protein (CRP) levels, consistent with a bacterial infection secondary to the stingray injury (<xref ref-type="table" rid="tab1">Table 1</xref>). During hospitalization, the patient was treated with intravenous ciprofloxacin (400&#x202F;mg every 12&#x202F;h) and clindamycin (600&#x202F;mg every 6&#x202F;h) for 18&#x202F;days. Additionally, his treatment included daily conventional wound care using collagenase and mechanical surgical debridement to manage the necrotic tissue and promote healing.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Evolution of laboratory findings following freshwater stingray injury (Case 01)&#x002A;.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Date</th>
<th align="center" valign="top">13/05/2023</th>
<th align="center" valign="top">16/05/2023</th>
<th align="center" valign="top">21/05/2023</th>
<th align="center" valign="top">30/05/2023</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Leukocytes (x10<sup>3</sup>/&#x03BC;L)</td>
<td align="char" valign="top" char=".">13.18</td>
<td align="char" valign="top" char=".">9.7</td>
<td align="char" valign="top" char=".">7.41</td>
<td align="char" valign="top" char=".">5.7</td>
</tr>
<tr>
<td align="left" valign="top">Neutrophils (%)</td>
<td align="char" valign="top" char=".">76.4</td>
<td align="char" valign="top" char=".">62.2</td>
<td align="char" valign="top" char=".">53.9</td>
<td align="char" valign="top" char=".">57.3</td>
</tr>
<tr>
<td align="left" valign="top">Lymphocytes (%)</td>
<td align="char" valign="top" char=".">13.1</td>
<td align="char" valign="top" char=".">23.2</td>
<td align="char" valign="top" char=".">31.7</td>
<td align="char" valign="top" char=".">27.4</td>
</tr>
<tr>
<td align="left" valign="top">Hemoglobin (g/dL)</td>
<td align="char" valign="top" char=".">12</td>
<td align="char" valign="top" char=".">11.7</td>
<td align="char" valign="top" char=".">12</td>
<td align="char" valign="top" char=".">11.2</td>
</tr>
<tr>
<td align="left" valign="top">Hematocrit (%)</td>
<td align="char" valign="top" char=".">36.9</td>
<td align="char" valign="top" char=".">35.3</td>
<td align="char" valign="top" char=".">36.8</td>
<td align="char" valign="top" char=".">35.1</td>
</tr>
<tr>
<td align="left" valign="top">Platelets (x10<sup>3</sup>/&#x03BC;L)</td>
<td align="char" valign="top" char=".">283</td>
<td align="char" valign="top" char=".">355</td>
<td align="char" valign="top" char=".">475</td>
<td align="char" valign="top" char=".">451</td>
</tr>
<tr>
<td align="left" valign="top">Coagulation Tests</td>
<td align="char" valign="top" char=".">TAP 14<break/>INR 1.07<break/>TTPA 32.1</td>
<td align="char" valign="top" char=".">TAP 13.4<break/>INR 1.01<break/>TTPA 28</td>
<td align="char" valign="top" char=".">TP 14.3<break/>INR 1.09<break/>TTPA 29.1</td>
<td align="char" valign="top" char=".">TP 14.3<break/>INR 1.2<break/>TTPA 29.2</td>
</tr>
<tr>
<td align="left" valign="top">C-Reactive Protein (mg/L)</td>
<td align="char" valign="top" char=".">178.01</td>
<td align="char" valign="top" char=".">164.11</td>
<td align="char" valign="top" char=".">56.47</td>
<td align="char" valign="top" char=".">17.46</td>
</tr>
<tr>
<td align="left" valign="top">Albumin (g/dL)</td>
<td/>
<td align="char" valign="top" char=".">2,93</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Urea/Creatinine (mg/dL)</td>
<td align="char" valign="top" char=".">26.76/1.07</td>
<td align="char" valign="top" char=".">21,52/0,98</td>
<td align="char" valign="top" char=".">31.5/ 1.02</td>
<td align="char" valign="top" char=".">29.83/1.14</td>
</tr>
<tr>
<td align="left" valign="top">AST/ALT (U/L)</td>
<td align="char" valign="top" char=".">12.26/15.5</td>
<td align="char" valign="top" char=".">11.95/11.39</td>
<td align="char" valign="top" char=".">12.14/ 14.71</td>
<td align="char" valign="top" char=".">13.46/ 15.12</td>
</tr>
<tr>
<td align="left" valign="top">Total Bilirubin / Direct Bilirubin / Indirect Bilirubin (mg/dL)</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">0.25/0.13/0.12</td>
<td align="char" valign="top" char=".">&#x2013;</td>
</tr>
<tr>
<td align="left" valign="top">LDH (U/L)</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">240,19</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>&#x002A;This table illustrates the progression of laboratory results during the hospitalization of Case 01.</p>
</table-wrap-foot>
</table-wrap>
<p>The wound on the patient&#x2019;s left ankle demonstrated a favorable progression, with effective infection control, the absence of necrotic tissue, and the development of healthy granulation tissue (<xref ref-type="fig" rid="fig1">Figure 1</xref>). These improvements were accompanied by significant normalization of laboratory findings. The patient was subsequently evaluated by the plastic surgery team, which recommended hospital discharge with continued outpatient follow-up at the complex wound care clinic. The post-discharge treatment plan included alternate-day wound dressings and regular monitoring for secondary intention healing, which was successfully achieved 6&#x202F;months after discharge.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Case 1: Progression of Wound Healing Following Freshwater Stingray Injury. <bold>(A)</bold> Ulcerated lesion with devitalized tissue and significant limb edema. <bold>(B)</bold> Post-operative wound after debridement and irrigation, with healthier edges and reduced edema. <bold>(C)</bold> Outpatient follow-up showing substantial healing. <bold>(D</bold>) Fully healed wound 6&#x202F;months after hospital discharge.</p>
</caption>
<graphic xlink:href="fmed-12-1536540-g001.tif"/>
</fig>
</sec>
<sec id="sec4">
<title>Case report 2</title>
<p>A 29-year-old male fisherman from Amajari, Roraima, with no prior medical history and use of routine medications, was admitted to the General Hospital of Roraima (HGR) on May 6, 2023, 2&#x202F;days after a stingray injury to the medial malleolar region, extending to the dorsum of the right foot. Upon admission, he presented with fever, edema, severe pain in the right lower limb, necrosis, and purulent discharge from the wound. Hospitalization was initiated, and intravenous antibiotic therapy with ceftriaxone and clindamycin was started. The patient was transferred to Block B under the care of the infectious disease team on May 8, 2023.</p>
<p>Laboratory tests (<xref ref-type="table" rid="tab2">Table 2</xref>) revealed leukocytosis (30 &#x00D7;10<sup>3</sup>/&#x03BC;L), neutrophilia (94.8%), and an elevated C-reactive protein (CRP) level of 159&#x202F;mg/L. Based on these findings, antibiotic therapy was escalated to piperacillin-tazobactam (4.5&#x202F;g IV every 6&#x202F;h).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Evolution of laboratory findings following freshwater stingray injury (Case 02)&#x002A;.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Date</th>
<th align="center" valign="top">06/05/2023</th>
<th align="center" valign="top">11/05/2023</th>
<th align="center" valign="top">14/05/2023</th>
<th align="center" valign="top">16/05/2023</th>
<th align="center" valign="top">21/05/2023</th>
<th align="center" valign="top">30/05/2023</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Leukocytes (x10<sup>3</sup>/&#x03BC;L)</td>
<td align="char" valign="top" char=".">30</td>
<td align="char" valign="top" char=".">19.26</td>
<td align="char" valign="top" char=".">14.09</td>
<td align="char" valign="top" char=".">8.37</td>
<td align="char" valign="top" char=".">6.42</td>
<td align="char" valign="top" char=".">4.61</td>
</tr>
<tr>
<td align="left" valign="top">Neutrophils (%)</td>
<td align="char" valign="top" char=".">94.8</td>
<td align="char" valign="top" char=".">83.6</td>
<td align="char" valign="top" char=".">75.5</td>
<td align="char" valign="top" char=".">71.5</td>
<td align="char" valign="top" char=".">57.7</td>
<td align="char" valign="top" char=".">45.7</td>
</tr>
<tr>
<td align="left" valign="top">Lymphocytes (%)</td>
<td align="char" valign="top" char=".">1.9</td>
<td align="char" valign="top" char=".">9.3</td>
<td align="char" valign="top" char=".">18.6</td>
<td align="char" valign="top" char=".">22.7</td>
<td align="char" valign="top" char=".">32.4</td>
<td align="char" valign="top" char=".">37.6</td>
</tr>
<tr>
<td align="left" valign="top">Hemoglobin (g/dL)</td>
<td align="char" valign="top" char=".">13.6</td>
<td align="char" valign="top" char=".">12.5</td>
<td align="char" valign="top" char=".">13</td>
<td align="char" valign="top" char=".">13</td>
<td align="char" valign="top" char=".">12.5</td>
<td align="char" valign="top" char=".">12.1</td>
</tr>
<tr>
<td align="left" valign="top">Hematocrit (%)</td>
<td align="char" valign="top" char=".">39.5</td>
<td align="char" valign="top" char=".">37.4</td>
<td align="char" valign="top" char=".">39</td>
<td align="char" valign="top" char=".">39.9</td>
<td align="char" valign="top" char=".">38</td>
<td align="char" valign="top" char=".">36.1</td>
</tr>
<tr>
<td align="left" valign="top">Platelets (x10<sup>3</sup>/&#x03BC;L)</td>
<td align="char" valign="top" char=".">209</td>
<td align="char" valign="top" char=".">301</td>
<td align="char" valign="top" char=".">400</td>
<td align="char" valign="top" char=".">411</td>
<td align="char" valign="top" char=".">487</td>
<td align="char" valign="top" char=".">278</td>
</tr>
<tr>
<td align="left" valign="top">Coagulation Tests</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">TAP13.1<break/>INR 1<break/>TTPA 35.7</td>
<td align="char" valign="top" char=".">TAP 13.3<break/>INR 1<break/>TTPA 34.3</td>
<td align="char" valign="top" char=".">TAP 13.4<break/>INR 1.01<break/>TTPA 35</td>
<td align="char" valign="top" char=".">TP 14.4<break/>RNI 1.1<break/>TTPA 37.2</td>
<td align="char" valign="top" char=".">TP 13.3<break/>RNI 1.11<break/>TTPA 28.6</td>
</tr>
<tr>
<td align="left" valign="top">C-Reactive Protein (mg/L)</td>
<td align="char" valign="top" char=".">159.51</td>
<td align="char" valign="top" char=".">112.52</td>
<td align="char" valign="top" char=".">68.4</td>
<td align="char" valign="top" char=".">21.51</td>
<td align="char" valign="top" char=".">11.44</td>
<td align="char" valign="top" char=".">4.41</td>
</tr>
<tr>
<td align="left" valign="top">Albumin (g/dL)</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">2.69</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">3.21</td>
<td align="char" valign="top" char=".">3.5</td>
<td align="char" valign="top" char=".">&#x2013;</td>
</tr>
<tr>
<td align="left" valign="top">Urea/Creatinine (mg/dL)</td>
<td align="char" valign="top" char=".">24.49/1.11</td>
<td align="char" valign="top" char=".">21.88/0.86</td>
<td align="char" valign="top" char=".">16.4/1.01</td>
<td align="char" valign="top" char=".">28.95/0.9</td>
<td align="char" valign="top" char=".">23.1/ 0.9</td>
<td align="char" valign="top" char=".">17.01/ 1.17</td>
</tr>
<tr>
<td align="left" valign="top">AST/ALT (U/L)</td>
<td align="char" valign="top" char=".">48.01/72.58</td>
<td align="char" valign="top" char=".">52.37/98.3</td>
<td align="char" valign="top" char=".">36.56/66.21</td>
<td align="char" valign="top" char=".">38.13/70.3</td>
<td align="char" valign="top" char=".">26.33/ 37.43</td>
<td align="char" valign="top" char=".">19.45/ 25.6</td>
</tr>
<tr>
<td align="left" valign="top">Total Bilirubin/Direct Bilirubin/Indirect Bilirubin (mg/dL)</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">0.54/0.21/0.33</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">0.43/0.25/0.18</td>
<td align="char" valign="top" char=".">0.37/0.23/0.14</td>
</tr>
<tr>
<td align="left" valign="top">LDH (U/L)</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">324.83</td>
<td align="char" valign="top" char=".">281.95</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">&#x2013;</td>
<td align="char" valign="top" char=".">237.8</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>&#x002A;This table illustrates the progression of laboratory results during the hospitalization of Case 02. In yellow values referring to the exams before the NPWT; in blue values referring during the NPWT; and in green values referring after the NPWT.</p>
</table-wrap-foot>
</table-wrap>
<p>In yellow values referring to the exams before the NPWT; in blue values referring during the NPWT; and in green values referring after the NPWT.</p>
<p>On May 17, surgical debridement was performed to remove necrotic tissue, and 48&#x202F;h later (May 19), Negative Pressure Wound Therapy (NPWT) was initiated (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Pressure was applied consistently and maintained at 125&#x202F;mmHg during the therapy. Following favorable progress with NPWT, granulation tissue covered a significant portion of the wound, with only minor residual necrotic areas. The wound dressing was removed on May 27, after 8&#x202F;days. A second surgical procedure was performed by the plastic surgery team, involving debridement of the remaining necrotic tissue and the application of an autologous skin graft on May 29.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Case 2: Progression of Wound Healing Following Freshwater Stingray Injury. <bold>(A)</bold> Ulcerated lesion with devitalized, flaccid tissue, and extensive edema and necrosis. <bold>(B)</bold> Immediate post-operative appearance following surgical debridement of necrotic and devitalized tissue. <bold>(C)</bold> Application of Negative Pressure Wound Therapy (NPWT). <bold>(D)</bold> Wound after NPWT removal, showing granulation tissue, absence of purulent exudate, and no necrotic areas. <bold>(E)</bold> Immediate post-operative appearance after autologous skin grafting.</p>
</caption>
<graphic xlink:href="fmed-12-1536540-g002.tif"/>
</fig>
<p>The patient was discharged on June 6, 2023, with significant laboratory improvement. The skin graft showed good acceptance, and the patient was scheduled for outpatient follow-up to monitor the wound until complete resolution.</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec5">
<title>Discussion</title>
<p>Stingray injuries pose a serious public health issue, especially in regions like the Amazon, where there is a high overlap between human activity in riverine areas and freshwater stingray habitats. Epidemiological data show that men, particularly fishermen, riverine workers, and individuals engaged in recreational activities in shallow waters, are most commonly affected. Injuries typically involve the feet and lower limbs and are more frequent during the dry season when river levels drop, increasing human exposure in these areas (<xref ref-type="bibr" rid="ref19">19</xref>). Despite their prevalence, these injuries are often underreported and receive less attention in public health discussions compared to other envenomations such as snakebites and spider bites.</p>
<p>The complications from stingray injuries can be severe, including intense pain, significant edema, erythema, tissue necrosis, and the development of deep ulcers. These wounds often require surgical debridement to remove dead tissue, as well as antibiotic therapy to treat secondary bacterial infections (<xref ref-type="bibr" rid="ref6">6</xref>). In addition to local complications, some patients may experience systemic symptoms. These range from mild issues such as nausea and vomiting to severe manifestations like respiratory depression, muscle fasciculations, and convulsions, which further complicate management (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>A study conducted in Bel&#x00E9;m, Par&#x00E1;, Brazil, examined stingray injuries over a 10-year period, revealing that nearly 89.2% of cases required wound debridement due to localized infections and necrosis (<xref ref-type="bibr" rid="ref19">19</xref>). This highlights the necessity of timely medical care and effective wound management strategies. However, traditional healing by secondary intention, while sometimes effective, can be prolonged. This extended recovery increases healthcare costs, delays patients&#x2019; return to daily activities and diminishes overall quality of life.</p>
<p>Negative Pressure Wound Therapy (NPWT) has emerged as an innovative and effective approach to wound management in such cases. By applying controlled subatmospheric pressure, NPWT creates an optimal healing environment. It reduces edema, lowers bacterial counts, removes wound exudates and debris, and promotes the formation of granulation tissue. Additionally, NPWT enhances blood flow to the wound and minimizes the risk of secondary infections, making it an invaluable tool for managing complex injuries, including those caused by envenomation (<xref ref-type="bibr" rid="ref20">20</xref>).</p>
<p>In this study, Case 01 followed a conventional treatment approach and experienced a longer recovery period, with wound closure achieved by secondary intention. Although the patient ultimately healed, the extended timeline required repeated wound care, which increased financial and emotional strain on both the patient and their family. Prolonged hospitalization and delayed recovery also increased the risk of secondary complications, underscoring the limitations of traditional wound management methods (<xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref22">22</xref>).</p>
<p>Conversely, Case 02 illustrates the transformative potential of NPWT. After surgical debridement, NPWT helped establish a clean wound bed with healthy granulation tissue, free from purulent exudate, necrosis, or edema. This prepared the wound for early skin grafting and tertiary closure, leading to faster healing, shorter hospitalization, and improved cosmetic and functional outcomes. The reduced recovery time and fewer complications highlight the cost-effectiveness of NPWT, aligning with findings from previous studies that emphasize its benefits in complex wound care (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>).</p>
<p>The comparison between these cases demonstrates the clear advantages of NPWT over standard care. By promoting faster wound closure and reducing complications, NPWT offers a more efficient and patient-centered solution. In addition to its clinical benefits, NPWT also significantly contributes to improving the life quality by reducing the pain associated with stingray wounds, which is often intense due to the venom and infection. The decrease in edema and removal of inflammatory mediators provide noticeable relief, reducing the daily discomfort of patients and improving their activity levels (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>). For patients with deep injuries, the NPWT therapy can restore self-esteem by improving the appearance of the wound and reducing visible scarring.</p>
<p>Furthermore, its adaptability to various types of wounds, including those complicated by necrosis and infection, underscores its value in resource-constrained environments like the Amazon, where access to advanced medical treatments is often limited. Beyond individual patient benefits, NPWT has broader implications for public health. By reducing the length of hospital stays and minimizing complications, NPWT lowers overall healthcare costs, an essential consideration for regions with limited resources. Moreover, NPWT enables patients to feel more secure and less anxious and stressed about the recovery process, directly contributing to their emotional and psychological well-being. The therapy can also promote a more efficient physical recovery allowing individuals to re-engage in their daily routines with fewer limitations allowing the patients to typically return to their daily lives and work more quickly, lessening the socio-economic burden on families and communities (<xref ref-type="bibr" rid="ref24">24</xref>&#x2013;<xref ref-type="bibr" rid="ref26">26</xref>).</p>
<p>However, the widespread implementation of NPWT faces challenges, particularly in remote and underserved areas. These include the availability of the necessary equipment, the need for trained professionals, and the financial cost of integrating NPWT into public healthcare systems. Addressing these barriers will require investments in infrastructure, training programs for healthcare providers, and strategic partnerships to make NPWT more accessible to those in need (<xref ref-type="bibr" rid="ref27">27</xref>).</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="ethics-statement" id="sec7">
<title>Ethics statement</title>
<p>The study received approval from the Research Ethics Committee of the Federal University of Roraima under protocol number CAAE 68511323.7.0000.5302, granted on April 17, 2023. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec sec-type="author-contributions" id="sec8">
<title>Author contributions</title>
<p>JN: Conceptualization, Investigation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. VB-d-F: Investigation, Visualization, Writing &#x2013; review &#x0026; editing. AM: Investigation, Visualization, Writing &#x2013; review &#x0026; editing. ET: Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. FC: Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. DD: Visualization, Writing &#x2013; review &#x0026; editing. AL: Visualization, Writing &#x2013; review &#x0026; editing. LG: Investigation, Visualization, Writing &#x2013; review &#x0026; editing. RC: Conceptualization, Investigation, Supervision, Visualization, Writing &#x2013; review &#x0026; editing. MP: Conceptualization, Funding acquisition, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. We thank Funda&#x00E7;&#x00E3;o de Amparo &#x00E0; Pesquisa do Estado de S&#x00E3;o Paulo (FAPESP; scholarship to E.T.F. No. 2024/13258&#x2013;0 and M.R. No. 2024/01801&#x2013;1), Conselho Nacional de Desenvolvimento Cient&#x00ED;fico e Tecnol&#x00F3;gico (CNPq, scholarship to M.P. No. 305778/2023&#x2013;4).</p>
</sec>
<sec sec-type="COI-statement" id="sec10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="sec11">
<title>Generative AI statement</title>
<p>The authors declare that Gen AI was used in the creation of this manuscript. Artificial intelligence (ChatGPT-4) was utilized solely to enhance the English grammar and clarity of the case reports, while all the information presented is original and newly generated.</p>
</sec>
<sec sec-type="disclaimer" id="sec12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garrone Neto</surname> <given-names>D</given-names></name> <name><surname>Haddad</surname> <given-names>JV</given-names></name></person-group>. <article-title>Arraias em rios da regi&#x00E3;o Sudeste do Brasil: locais de ocorr&#x00EA;ncia e impactos sobre a popula&#x00E7;&#x00E3;o</article-title>. <source>Rev Soc Bras Med Trop</source>. (<year>2010</year>) <volume>43</volume>:<fpage>82</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1590/S0037-86822010000100018</pub-id>, PMID: <pub-id pub-id-type="pmid">20305975</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magalhaes</surname> <given-names>KW</given-names></name> <name><surname>Lima</surname> <given-names>C</given-names></name> <name><surname>Piran-Soares</surname> <given-names>AA</given-names></name> <name><surname>Marques</surname> <given-names>EE</given-names></name> <name><surname>Hiruma-Lima</surname> <given-names>CA</given-names></name> <name><surname>Lopes-Ferreira</surname> <given-names>M</given-names></name></person-group>. <article-title>Biological and biochemical properties of the Brazilian Potamotrygon stingrays: <italic>Potamotrygon</italic> cf. <italic>scobina</italic> and <italic>Potamotrygon</italic> gr. <italic>orbignyi</italic></article-title>. <source>Toxicon</source>. (<year>2006</year>) <volume>47</volume>:<fpage>575</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.toxicon.2006.01.028</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>YL</given-names></name> <name><surname>Kumarasinghe</surname> <given-names>SPW</given-names></name></person-group>. <article-title>Cutaneous injuries from marine animals</article-title>. <source>Singapore Med J</source>. (<year>2007</year>) <volume>48</volume>:<fpage>e25</fpage>&#x2013;<lpage>8</lpage>. PMID: <pub-id pub-id-type="pmid">17245501</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanc Brisset</surname> <given-names>I</given-names></name> <name><surname>Schaper</surname> <given-names>A</given-names></name> <name><surname>Pommier</surname> <given-names>P</given-names></name> <name><surname>De Haro</surname> <given-names>L</given-names></name></person-group>. <article-title>Envenomation by Amazonian freshwater stingray <italic>Potamotrygon motoro</italic>: 2 cases reported in Europe</article-title>. <source>Toxicon</source>. (<year>2006</year>) <volume>47</volume>:<fpage>32</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.toxicon.2005.09.005</pub-id>, PMID: <pub-id pub-id-type="pmid">16303158</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Lameiras</surname> <given-names>JLV</given-names></name> <name><surname>Duncan</surname> <given-names>WLP</given-names></name></person-group>. <italic>Arraias de &#x00C1;gua Doce (Chondrichthyes &#x2013; Potamotrygonidae)</italic>. Scientia Amazonia (<year>2013</year>).</citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="other"><person-group person-group-type="author"><collab id="coll1">Ferroada de Arraia Les&#x00F5;es</collab></person-group>. <italic>Intoxica&#x00E7;&#x00E3;o. Manuais MSD edi&#x00E7;&#x00E3;o para profissionais</italic>. Available at: <ext-link xlink:href="https://www.msdmanuals.com/pt/profissional/les&#x00F5;es-intoxica&#x00E7;&#x00E3;o/mordidas-e-picadas/ferroada-de-arraia" ext-link-type="uri">https://www.msdmanuals.com/pt/profissional/les&#x00F5;es-intoxica&#x00E7;&#x00E3;o/mordidas-e-picadas/ferroada-de-arraia</ext-link> (Accessed January 21, 2025).</citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname> <given-names>V</given-names></name> <name><surname>Neto</surname> <given-names>DG</given-names></name> <name><surname>De Paula Neto</surname> <given-names>JB</given-names></name> <name><surname>De Luna Marques</surname> <given-names>FP</given-names></name> <name><surname>Barbaro</surname> <given-names>KC</given-names></name></person-group>. <article-title>Freshwater stingrays: study of epidemiologic, clinic and therapeutic aspects based on 84 envenomings in humans and some enzymatic activities of the venom</article-title>. <source>Toxicon</source>. (<year>2004</year>) <volume>43</volume>:<fpage>287</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.toxicon.2003.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">15033327</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forrester</surname> <given-names>MB</given-names></name></person-group>. <article-title>Pattern of stingray injuries reported to Texas poison centers from 1998 to 2004</article-title>. <source>Hum Exp Toxicol</source>. (<year>2005</year>) <volume>24</volume>:<fpage>639</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1191/0960327105ht566oa</pub-id>, PMID: <pub-id pub-id-type="pmid">16408617</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Charvet-Almeida</surname> <given-names>P</given-names></name> <name><surname>G&#x00F3;es</surname> <given-names>ML</given-names></name></person-group>. <italic>Neotropical freshwater stingrays: Diversity and conservation status</italic>. (<year>2008</year>). <comment>Available at:</comment> <ext-link xlink:href="https://www.semanticscholar.org/paper/Neotropical-Freshwater-Stingrays%3A-diversity-and-Charvet-Almeida-G%C3%B3es/8bd95be25a3b3303aefbd13f014417ca40d1ac99" ext-link-type="uri">https://www.semanticscholar.org/paper/Neotropical-Freshwater-Stingrays%3A-diversity-and-Charvet-Almeida-G%C3%B3es/8bd95be25a3b3303aefbd13f014417ca40d1ac99</ext-link> (Accessed January 21, 2025).</citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Zaver</surname> <given-names>V</given-names></name> <name><surname>Kankanalu</surname> <given-names>P</given-names></name></person-group>. <source>Negative pressure wound therapy</source>. <publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name> (<year>2025</year>).</citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname> <given-names>MES</given-names></name> <name><surname>Soares</surname> <given-names>FF</given-names></name> <name><surname>Feij&#x00F3;</surname> <given-names>R</given-names></name> <name><surname>MJL</surname> <given-names>P</given-names></name></person-group>. <article-title>Curativo de press&#x00E3;o negativa associado &#x00E0; matriz de regenera&#x00E7;&#x00E3;o d&#x00E9;rmica: an&#x00E1;lise da pega e do tempo de matura&#x00E7;&#x00E3;o</article-title>. <source>Revista Brasileira de Queimaduras</source>. (<year>2014</year>) <volume>13</volume>:<fpage>76</fpage>&#x2013;<lpage>82</lpage>.</citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname> <given-names>TL</given-names></name> <name><surname>Da Silva</surname> <given-names>AN</given-names></name> <name><surname>De Sousa</surname> <given-names>MB</given-names></name> <name><surname>Costa</surname> <given-names>MP</given-names></name> <name><surname>Da Rocha</surname> <given-names>JC</given-names></name> <etal/></person-group>. <article-title>Terapia por press&#x00E3;o negativa no tratamento de feridas</article-title>. <source>Rev. Eletr&#x00F4;n. Acervo Sa&#x00FA;de</source>. (<year>2019</year>) <volume>2019</volume>:<fpage>e1231</fpage>. doi: <pub-id pub-id-type="doi">10.25248/reas.e1231.2019</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname> <given-names>AG</given-names></name> <name><surname>Fortes</surname> <given-names>RC</given-names></name> <name><surname>Reis</surname> <given-names>CMS</given-names></name> <name><surname>Farias</surname> <given-names>PVS</given-names></name></person-group>. <article-title>Efeitos da terapia por press&#x00E3;o negativa na preven&#x00E7;&#x00E3;o de complica&#x00E7;&#x00F5;es em ferida cir&#x00FA;rgica de artoplastia total do joelho: um estudo baseado em evid&#x00EA;ncias</article-title>. <source>OLEL</source>. (<year>2024</year>) <volume>22</volume>:<fpage>e4490</fpage>. doi: <pub-id pub-id-type="doi">10.55905/oelv22n5-025</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Borges</surname> <given-names>MCM</given-names></name></person-group>. <italic>Terapia por press&#x00E3;o negativa no tratamento de les&#x00F5;es por press&#x00E3;o: revis&#x00E3;o da literatura</italic>. (<year>2023</year>). <comment>Available at:</comment> <ext-link xlink:href="https://repositorio.pucgoias.edu.br/jspui/handle/123456789/5916" ext-link-type="uri">https://repositorio.pucgoias.edu.br/jspui/handle/123456789/5916</ext-link> (Accessed January 21, 2025).</citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="other"><person-group person-group-type="author"><collab id="coll2">Terapia de Feridas com Press&#x00E3;o Negativa</collab></person-group>. <italic>Uma Revis&#x00E3;o de Seu Uso em Trauma Ortop&#x00E9;dico</italic>. HARTMANN GROUP. Available at: <ext-link xlink:href="https://www.hartmann.info/pt-br/blog-cientifico-hartmann/l/br/terapia-de-feridas-com-pressao-negativa-uma-revisao-de-seu-uso-em-trauma-ortopedico" ext-link-type="uri">https://www.hartmann.info/pt-br/blog-cientifico-hartmann/l/br/terapia-de-feridas-com-pressao-negativa-uma-revisao-de-seu-uso-em-trauma-ortopedico</ext-link> (Accessed January 21, 2025).</citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Souza</surname> <given-names>BR</given-names></name> <name><surname>Alencar</surname> <given-names>ACDA</given-names></name> <name><surname>Barletta</surname> <given-names>CAB</given-names></name> <name><surname>De Sousa</surname> <given-names>AZSF</given-names></name> <name><surname>Da Costa</surname> <given-names>JB</given-names></name> <name><surname>De Lima</surname> <given-names>AB</given-names></name> <etal/></person-group>. <article-title>Terapia por press&#x00E3;o negativa em feridas traum&#x00E1;ticas</article-title>. <source>BJDV</source>. (<year>2021</year>) <volume>7</volume>:<fpage>117100</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.34117/bjdv7n12-458</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname> <given-names>MC</given-names></name> <name><surname>Paggiaro</surname> <given-names>AO</given-names></name></person-group>. <article-title>Terapia por press&#x00E3;o negativa-v&#x00E1;cuo</article-title>. <source>Rev Med (S&#x00E3;o Paulo)</source>. (<year>2010</year>) <volume>89</volume>:<fpage>142</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.11606/issn.1679-9836.v89i3/4p142-146</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>PK</given-names></name></person-group>. <article-title>Stingray injuries</article-title>. <source>Wilderness Environ Med</source>. (<year>1997</year>) <volume>8</volume>:<fpage>24</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1580/1080-6032(1997)008[0024:si]2.3.co;2</pub-id>, PMID: <pub-id pub-id-type="pmid">11990133</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Oliveira</surname> <given-names>P</given-names></name> <name><surname>Parda</surname> <given-names>P</given-names></name> <name><surname>Pires</surname> <given-names>WM</given-names></name> <name><surname>Borba</surname> <given-names>P</given-names></name> <name><surname>Ferreira</surname> <given-names>H</given-names></name> <name><surname>Messias Oliveira Brito</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Freshwater stingray injuries in Bel&#x00E9;m, state of Par&#x00E1;, Brazil</article-title>. <source>J Health NPEPS</source>. (<year>2020</year>) <volume>5</volume>:<fpage>99</fpage>&#x2013;<lpage>115</lpage>. doi: <pub-id pub-id-type="doi">10.30681/252610104423</pub-id>, PMID: <pub-id pub-id-type="pmid">30304272</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Normandin</surname> <given-names>S</given-names></name> <name><surname>Safran</surname> <given-names>T</given-names></name> <name><surname>Winocour</surname> <given-names>S</given-names></name> <name><surname>Chu</surname> <given-names>CK</given-names></name> <name><surname>Vorstenbosch</surname> <given-names>J</given-names></name> <name><surname>Murphy</surname> <given-names>AM</given-names></name> <etal/></person-group>. <article-title>Negative pressure wound therapy: mechanism of action and clinical applications</article-title>. <source>Semin Plast Surg</source>. (<year>2021</year>) <volume>35</volume>:<fpage>164</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0041-1731792</pub-id>, PMID: <pub-id pub-id-type="pmid">34526864</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCaughan</surname> <given-names>D</given-names></name> <name><surname>Sheard</surname> <given-names>L</given-names></name> <name><surname>Cullum</surname> <given-names>N</given-names></name> <name><surname>Dumville</surname> <given-names>J</given-names></name> <name><surname>Chetter</surname> <given-names>I</given-names></name></person-group>. <article-title>Patients&#x2019; perceptions and experiences of living with a surgical wound healing by secondary intention: a qualitative study</article-title>. <source>Int J Nurs Stud</source>. (<year>2018</year>) <volume>77</volume>:<fpage>29</fpage>&#x2013;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijnurstu.2017.09.015</pub-id>, PMID: <pub-id pub-id-type="pmid">29031127</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chetter</surname> <given-names>IC</given-names></name> <name><surname>Oswald</surname> <given-names>AV</given-names></name> <name><surname>McGinnis</surname> <given-names>E</given-names></name> <name><surname>Stubbs</surname> <given-names>N</given-names></name> <name><surname>Arundel</surname> <given-names>C</given-names></name> <name><surname>Buckley</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Patients with surgical wounds healing by secondary intention: a prospective, cohort study</article-title>. <source>Int J Nurs Stud</source>. (<year>2019</year>) <volume>89</volume>:<fpage>62</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijnurstu.2018.09.011</pub-id>, PMID: <pub-id pub-id-type="pmid">30343210</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>DDA</given-names></name> <name><surname>Neves Filho</surname> <given-names>WV</given-names></name> <name><surname>Guimar&#x00E3;es</surname> <given-names>JDS</given-names></name> <name><surname>Castro</surname> <given-names>DDA</given-names></name> <name><surname>Ferracini</surname> <given-names>AM</given-names></name></person-group>. <article-title>The use of negative pressure wound therapy in the treatment of infected wounds</article-title>. <source>Case Stud Rev Bras Ortop (Engl Ed)</source>. (<year>2016</year>) <volume>51</volume>:<fpage>646</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.rboe.2016.10.014</pub-id>, PMID: <pub-id pub-id-type="pmid">28050534</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname> <given-names>G</given-names></name> <name><surname>Shi</surname> <given-names>C</given-names></name> <name><surname>Goh</surname> <given-names>EL</given-names></name> <name><surname>Murphy</surname> <given-names>EM</given-names></name> <name><surname>Reid</surname> <given-names>A</given-names></name> <name><surname>Chiverton</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Negative pressure wound therapy for surgical wounds healing by primary closure</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2022</year>) <volume>2022</volume>:<fpage>CD009261</fpage>. doi: <pub-id pub-id-type="doi">10.1002/14651858.CD009261.pub7</pub-id>, PMID: <pub-id pub-id-type="pmid">35471497</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname> <given-names>RVKS</given-names></name> <name><surname>Coltro</surname> <given-names>PS</given-names></name> <name><surname>Farina J&#x00FA;nior</surname> <given-names>JA</given-names></name></person-group>. <article-title>Negative pressure therapy for the treatment of complex wounds</article-title>. <source>Rev Col Bras Cir</source>. (<year>2017</year>) <volume>44</volume>:<fpage>81</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1590/0100-69912017001001</pub-id>, PMID: <pub-id pub-id-type="pmid">28489215</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname> <given-names>A</given-names></name> <name><surname>Wasim</surname> <given-names>J</given-names></name> <name><surname>Palmer</surname> <given-names>P</given-names></name></person-group>. <article-title>The evidence-based principles of negative pressure wound therapy in Trauma &#x0026; Orthopedics</article-title>. <source>TOORTHJ</source>. (<year>2014</year>) <volume>8</volume>:<fpage>168</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1874325001408010168</pub-id>, PMID: <pub-id pub-id-type="pmid">25067971</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray-Ramcharan</surname> <given-names>M</given-names></name> <name><surname>Feltes Escurra</surname> <given-names>M</given-names></name> <name><surname>Engdahl</surname> <given-names>R</given-names></name> <name><surname>Gattorno</surname> <given-names>FL</given-names></name></person-group>. <article-title>Negative-pressure wound therapy for the Management of Complex Surgical Wounds in a minority population</article-title>. <source>Cureus</source>. (<year>2024</year>) <volume>16</volume>:<fpage>e56726</fpage>. doi: <pub-id pub-id-type="doi">10.7759/cureus.56726</pub-id>, PMID: <pub-id pub-id-type="pmid">38646389</pub-id></citation></ref>
</ref-list>
</back>
</article>